AlphAIAlphAI — Financial news for AI agents
investing.com$IEX

DA Davidson raises IDEX stock price target to $245 on strength

DA Davidson raised its price target on IDEX Corp (NYSE:IEX) to $245 from $240, citing strength in its Health & Science Technologies and Fire & Safety segments. The stock has risen 39% over the past year. IDEX reported Q3 2026 earnings of $2.33 per share, beating estimates, with revenue of $952 million. The company also raised its full-year guidance.

Original reporting
investing.com
Published Oct 29, 2026, 2:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$IEX
Bullish
high confidence
Mentioned
$IEX
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$IEXBullishHigh
01

Why it matters

The analyst's target raise and earnings beat provide a fresh catalyst that could drive short‑term buying interest.

02

Market read

The new earnings data and target raise constitute primary news for IDEX, offering a clear trading signal.

03

What to watch

Potential supply-chain constraints in semiconductor components could temper future growth.

Relevance 8/10Novelty 8/10Timing: today

Background

DA Davidson's upgrade follows IDEX's Q3 2026 earnings beat and a raised full-year outlook, reflecting strength in its Health & Science Technologies segment.

Company-level read

Ticker impact

$IEXBullishHigh confidence
Context

DA Davidson raised IDEX price target to $245 and highlighted Q3 2026 earnings beat and raised full-year guidance.

Expected impact

likely upward pressure as the market prices in the higher target and guidance

Evidence & confidence

Target raise to $245 from $240 and earnings beat are fresh, material information for investors.

Market effects

Sector

Industrial equipment sector may see modest uplift as IDEX's strong results highlight demand in data centers, defense, and water markets.

Regional

U.S. industrial stocks could benefit from the positive earnings backdrop.

Global

Limited to investors tracking U.S. industrial and technology equipment exposure.

Counterpoint

What could challenge this read

The price target increase is modest and may already be priced in; the stock could face headwinds if macro demand softens.

Key entities

  • company
    IDEX Corp

    Industrial equipment manufacturer (ticker IEX).

  • analyst
    DA Davidson

    Equity research firm that raised the price target.

Read at source← All news

StoryIDEX beats third-quarter expectations and raises 2026 outlook

Also covered by

3 outlets

Related articles

$IEXMedAI 8/10

Idex: Q3 Earnings Snapshot

IDEX Corp. (IEX) reported Q3 net income of $144.1M, or $1.95 per share, exceeding analyst estimates. Adjusted EPS was $2.33. Revenue was $951.7M, also beating forecasts. The company raised its full-year EPS guidance to $8.91-$8.96 per share.

finance.yahoo.com
$IEXHighAI 8/10

IDEX (IEX) Q3 2026 Earnings Call Transcript

IDEX (IEX) reported Q3 2026 net sales of $952M, up 8%, and adjusted EPS of $2.33, up 15%. Organic orders reached $991M, growing 13%. HST, FMT, and FSDP segments showed growth. Full-year guidance raised: organic growth 6.5-6.8%, adjusted EPS $8.91-$8.96. Inflation and chemical sector weakness noted as risks.

fool.com
$IEXHighAI 8/10

IDEX Q3 2026 slides: advantaged markets drive beat, guidance raised

IDEX Corporation (NYSE:IEX) reported Q3 2026 earnings with 8% organic sales growth and 15% increase in adjusted EPS, driven by 'advantaged markets'. Sales reached $952M, adjusted EBITDA margin expanded to 27.8%, and free cash flow grew 14%. The company raised its full-year outlook, with shares up 0.92% to $235.35. HST segment led growth with 13% organic sales growth.

investing.com
$IEXMedAI 8/10

IDEX (NYSE:IEX) beats Q3 2026 sales expectations

IDEX reported Q3 2026 revenue of $951.7 million, beating estimates by 1.8%. Adjusted EPS was $2.33, a 4% beat. Adjusted EBITDA reached $264.8 million, a 3.2% beat. Management raised full-year adjusted EPS guidance to $8.94. Operating margin remained steady at 21.9%, while free cash flow margin improved to 22.5%.

finance.yahoo.com
$IEXHighAI 9/10

IDEX beats estimates and lifts guidance as orders surge

IDEX Corporation (NYSE:IEX) reported Q3 earnings of $2.33 per share, beating estimates by $0.09, with revenue of $952M, up 8% YoY. Orders rose 13% to $991M. The company raised full-year EPS guidance to $8.91-$8.96 and increased organic sales growth outlook to 6.5%-6.8%. Shares rose 2.4% post-announcement. Growth was driven by AI and semiconductor demand, particularly in the Health & Science Technologies segment.

investing.com